WALTHAM, Mass., May 28, 2013 (GLOBE NEWSWIRE) -- TESARO, Inc. (Nasdaq:TSRO) invites investors and the general public to listen to a webcast of a presentation by the TESARO management team at an investor briefing on Sunday, June 2, 2013 at 6:15 p.m. Central time, in connection with the annual meeting of the American Society of Clinical Oncology (ASCO). This briefing will include a discussion of clinical data and development plans for niraparib, in addition to a question and answer session.
This meeting will be webcast live and a replay will be available for 30 days. The live webcast and replay will be accessible at www.tesarobio.com.
TESARO, Inc. is an oncology-focused biopharmaceutical company dedicated to improving the lives of cancer patients.
CONTACT: Investor/Media Contact: Jennifer Davis Sr. Director, Corporate Development & Investor Relations +1.781.325.1116